JointStem

N/A

Report date: 2025/09/19 17:43:20

Base Information

Drug NameJointStem
Drug Alias NameAutologous adipose stem cells - K-STEMCELLFat-derived stem cell therapies - K-STEMCELLMesenchymal stem cell therapies - K-STEMCELLAdult-derived stem cell therapies - K-STEMCELLAutologous Adipose Tissue derived MSCs Transplantation - K-STEMCELL +[14] 
ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derived
Mechanisms of ActionOsteogenesis stimulantsTissue replacementsCell replacements +[4] 
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Primary Ovarian InsufficiencyAlzheimer Disease +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth KoreaMongolia
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesNature Cell Co LtdK-Stemcell
China Registration ClassN/A

Develop Information

Active CompaniesMongolian National University Of Medical SciencesR'BioNature Cell Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Primary Ovarian InsufficiencyAlzheimer Disease +[4] 
Inactive IndicationsCerebral PalsyOsteoarthritis

Other Information

ATC CodeN/A
Related LinksWikipedia